Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin

Vancomycin remains the mainstay of treatment for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. This study assessed risk factors for vancomycin failure in 63 patients with MRSA pneumonia through detailed clinical, microbiological, pharmacokinetic/pharmacodynamic, and genetic analyses...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ya-Xin, Chen, Meng-Ting, Li, Nan-Yang, Liu, Xiao-Fen, Yang, Min-Jie, Chen, Yuan-Cheng, Liang, Xiao-Yu, Wu, Ju-Fang, Guo, Bei-Ning, Song, Si-Chao, Zhu, Yong-Qiang, Zhang, Feng-Ying, Hang, Jing-Qing, Wu, Sheng-Bin, Shen, Bo, Li, Hua-Yin, Wang, Qin, Luo, Xu-Ming, Chen, Qing-Ge, Zhang, Hui-Fang, Wang, Rui-Lan, Shen, Li-Hua, Fu, Feng-Ming, Song, Xiao-Lian, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603198/
https://www.ncbi.nlm.nih.gov/pubmed/36094217
http://dx.doi.org/10.1128/spectrum.01348-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603198/
https://www.ncbi.nlm.nih.gov/pubmed/36094217
http://dx.doi.org/10.1128/spectrum.01348-22

Ejemplares similares